Nichols William Garrett, Chief Medical Officer of Candel Therapeutics, Inc. ($CADL), sold common shares on the open market three times in the last 365 days, totaling about $407,500. His most recent sale occurred on July 28, 2025. These sales rank 6,904th among 11,678 individual insiders in our database, where the average is $8.6 million across roughly 6.4 transactions. Garrett made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | A | Stock Option (Right to Buy) | 136500 | $0.00 | 136,500.0000 | 55,018,457 | 9999.99% | 0.25% |
| July 28, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 937 | $6.98 | 52,493.0000 | 55,012,239 | 1.75% | 0.00% |
| July 28, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Stock Option (Right to Buy) | 937 | $0.00 | 29,377.0000 | 55,012,239 | 3.09% | 0.00% |
| July 28, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Common Stock | 937 | $1.29 | 53,430.0000 | 55,012,239 | 1.79% | 0.00% |
| June 30, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 781 | $5.04 | 52,493.0000 | 46,933,088 | 1.47% | 0.00% |
| June 30, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Stock Option (Right to Buy) | 781 | $0.00 | 30,314.0000 | 46,933,088 | 2.51% | 0.00% |
| June 30, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Common Stock | 781 | $1.29 | 53,274.0000 | 46,933,088 | 1.49% | 0.00% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Common Stock | 13905 | $1.29 | 97,809.0000 | 46,933,088 | 16.57% | 0.03% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 45316 | $8.76 | 52,493.0000 | 46,933,088 | 46.33% | 0.10% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Stock Option (Right to Buy) | 4584 | $0.00 | 195,416.0000 | 46,933,088 | 2.29% | 0.01% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Stock Option (Right to Buy) | 13905 | $0.00 | 31,095.0000 | 46,933,088 | 30.90% | 0.03% |
| March 18, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | M | Common Stock | 4584 | $3.75 | 83,904.0000 | 46,933,088 | 5.78% | 0.01% |
| Feb. 12, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | A | Stock Option (Right to Buy) | 107250 | $0.00 | 107,250.0000 | 46,933,088 | 9999.99% | 0.23% |
| Jan. 15, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 10428 | $7.23 | 79,320.0000 | 46,933,088 | 11.62% | 0.02% |
| Jan. 8, 2025 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 10799 | $8.22 | 89,748.0000 | 46,933,088 | 10.74% | 0.02% |
| Nov. 29, 2024 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 13935 | $4.56 | 100,547.0000 | 32,247,744 | 12.17% | 0.04% |
| July 17, 2024 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 10875 | $6.47 | 114,482.0000 | 31,186,817 | 8.68% | 0.03% |
| July 11, 2024 | Candel Therapeutics, Inc. | $CADL | Nichols William Garrett | Chief Medical Officer | S | Common Stock | 9769 | $5.97 | 125,357.0000 | 31,186,817 | 7.23% | 0.03% |